Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Claudin-1, A Double-Edged Sword in Cancer.
Bhat AA, Syed N, Therachiyil L, Nisar S, Hashem S, Macha MA, Yadav SK, Krishnankutty R, Muralitharan S, Al-Naemi H, Bagga P, Reddy R, Dhawan P, Akobeng A, Uddin S, Frenneaux MP, El-Rifai W, Haris M. Bhat AA, et al. Among authors: therachiyil l. Int J Mol Sci. 2020 Jan 15;21(2):569. doi: 10.3390/ijms21020569. Int J Mol Sci. 2020. PMID: 31952355 Free PMC article. Review.
Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells.
Prabhu KS, Siveen KS, Kuttikrishnan S, Iskandarani A, Tsakou M, Achkar IW, Therachiyil L, Krishnankutty R, Parray A, Kulinski M, Merhi M, Dermime S, Mohammad RM, Uddin S. Prabhu KS, et al. Among authors: therachiyil l. PLoS One. 2017 Jul 13;12(7):e0180895. doi: 10.1371/journal.pone.0180895. eCollection 2017. PLoS One. 2017. PMID: 28704451 Free PMC article.
Exploring Dysregulated Signaling Pathways in Cancer.
Nisar S, Hashem S, Macha MA, Yadav SK, Muralitharan S, Therachiyil L, Sageena G, Al-Naemi H, Haris M, Bhat AA. Nisar S, et al. Among authors: therachiyil l. Curr Pharm Des. 2020;26(4):429-445. doi: 10.2174/1381612826666200115095937. Curr Pharm Des. 2020. PMID: 31939726 Review.
[No title available]
[No authors listed] [No authors listed] PMID: 35553830
Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents.
Hashem S, Ali TA, Akhtar S, Nisar S, Sageena G, Ali S, Al-Mannai S, Therachiyil L, Mir R, Elfaki I, Mir MM, Jamal F, Masoodi T, Uddin S, Singh M, Haris M, Macha M, Bhat AA. Hashem S, et al. Among authors: therachiyil l. Biomed Pharmacother. 2022 Jun;150:113054. doi: 10.1016/j.biopha.2022.113054. Epub 2022 Apr 30. Biomed Pharmacother. 2022. PMID: 35658225 Free article. Review.
21 results